D
Crinetics Pharmaceuticals, Inc. CRNX
$35.20 $0.732.12%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -34.11% -33.71% -45.27% -45.52% -33.58%
Total Depreciation and Amortization 200.76% 182.05% 168.93% 67.49% -6.43%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 18.60% 39.98% 73.43% 92.01% 82.44%
Change in Net Operating Assets -103.71% -144.33% 357.75% 491.85% 250.55%
Cash from Operations -67.92% -51.97% 0.26% -29.81% -9.40%
Capital Expenditure -10.05% 84.91% -302.95% -8,225.00% -241.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -526.42% 111.13% -266.34% -96.64% -332.64%
Cash from Investing -520.89% 110.66% -270.64% -99.37% -336.91%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,408.44% -83.63% -57.86% 84,483.47% 53,132.88%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3,337.65% 92.99% 104.00% -- -2,326.19%
Cash from Financing 1,360.88% -83.03% -56.58% 81,216.94% 32,878.26%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 40.02% -85.37% -5,613.71% 3,902.19% -5,091.37%
Weiss Ratings